Caring Brands (CABR) Revenue (2024 - 2025)
Caring Brands' (CABR) quarterly Revenue came in at $1586.0 in Q4 2025, up 241.08% year-on-year from $465.0 in Q4 2024, and up 114.32% quarter-over-quarter from $740.0 in Q3 2025.
Caring Brands (CABR) Revenue (2024 - 2025) Analysis & Trends
Caring Brands' Revenue history runs 2 years deep, the most recent figure standing at $1586.0 for Q4 2025.
- On a quarterly basis, Revenue rose 241.08% year-over-year to $1586.0 in Q4 2025; TTM through Dec 2025 was $4260.0, a N/A change from a year earlier, with the FY2025 full-year figure at $4215.0, changed N/A from the prior year.
- Revenue improved to $1586.0 in Q4 2025 per CABR's latest filing, from $740.0 in the prior quarter.
- Across five years, Revenue topped out at $1586.0 in Q4 2025 and bottomed at $465.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Caring Brands | 20.66 Mn | 18.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,586.00 |
| Sep 30, 2025 | 740.00 |
| Mar 31, 2025 | 1,469.00 |
| Dec 31, 2024 | 465.00 |